Daré Bioscience's market cap is currently ―. The company's EPS TTM is $-0.337; its P/E ratio is -0.88; Daré Bioscience is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 1.00M	-	-	-	$ 0.00
Gross Profit	$ 1.00M	-	-	-	-
EBIT	$ -8.25M	$ -8.71M	$ -8.04M	$ -15.94M	$ -7.14M
EBITDA	$ -8.24M	$ -8.70M	$ -8.03M	$ -15.93M	$ -7.14M
Net Income Common Stockholders	$ -8.30M	$ -8.76M	$ -8.04M	$ -15.94M	$ -7.02M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 13.90M	$ 13.30M	$ 19.83M	$ 34.67M	$ 40.39M
Total Assets	$ 25.05M	$ 23.18M	$ 30.37M	$ 43.83M	$ 50.38M
Total Debt	$ 195.00K	$ 295.00K	$ 393.00K	$ 488.00K	$ 582.72K
Net Debt	$ -13.71M	$ -13.01M	$ -19.44M	$ -34.18M	$ -39.81M
Total Liabilities	$ 27.34M	$ 25.94M	$ 25.37M	$ 32.71M	$ 24.03M
Stockholders Equity	$ -2.29M	$ -2.74M	$ 4.99M	$ 11.11M	$ 26.34M
Cash Flow	-
Free Cash Flow	$ -8.00M	$ -6.63M	$ -16.08M	$ -5.90M	$ 8.55M
Operating Cash Flow	$ -7.97M	$ -6.63M	$ -16.08M	$ -5.90M	$ 8.60M
Investing Cash Flow	$ -22.10K	-	-	$ -2.70K	$ -55.00K
Financing Cash Flow	$ 8.58M	$ 452.19K	$ 1.30M	$ -1.00	$ 4.46K

Currency in USD

Daré Bioscience Earnings and Revenue History

Income Statement >

Daré Bioscience Debt to Assets

Balance Sheet >

Daré Bioscience Cash Flow

Cash Flow >

Daré Bioscience Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing